
Cetrum Pharma-Consultant Private Limited
About Cetrum Pharma-Consultant Private Limited
Data last updated:
Cetrum Pharma-Consultant Private Limited is a private limited company based in Ludhiana, Punjab, India. It operates in the specialised services segment of the trading and commerce sector. It was incorporated on 16 March 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U51909PB2021PTC052998. Its GSTIN is 03AAJCC3568M1ZD (Punjab).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Ruchika Jain and Rakshit Jain.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Office II Iind Floor 308/1 Dr Sham Singh Road Civil Lines, Ludhiana, Punjab, India – 141001.
As per the financials filed for FY 2025, the company reported a revenue of ₹97.17 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹50.88 Lakh (net margin 52.4%) and EBITDA of ₹68.79 Lakh (EBITDA margin 70.8%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years.
Company details
Contact details
Cetrum Pharma-Consultant Private Limited's registered office is in Ludhiana, Punjab. Its e-mail address is in the company report.
- Email
- Registered AddressOffice II Iind Floor 308/1 Dr Sham Singh Road Civil Lines, Ludhiana, Punjab, India – 141001
- IndustryTrading, Specialty, Wholesale
To see the full contact details of Cetrum Pharma-Consultant Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cetrum Pharma-Consultant is support service to organizations. In detail, this covers other support services to organizations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| N | Support service to Organizations | N7 | Other support services to organizations |
To see the full business activity and turnover split of Cetrum Pharma-Consultant Private Limited, buy the company report.
Financials of Cetrum Pharma-Consultant Private Limited
FY 2025 filings availableCetrum Pharma-Consultant Private Limited reported revenue of ₹97.17 Lakh (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 13% over three years, including 9% growth in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹68.79 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹50.88 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 70.8% | ||||
| Net Profit Margin | 52.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cetrum Pharma-Consultant Private Limited, buy the company report.
Board of directors of Cetrum Pharma-Consultant Private Limited
Cetrum Pharma-Consultant has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ruchika Jain Also directs: VMR Biotech Private Limited | Director | 16 Mar 2021 | 5 Years 8 Months | Current |
| Rakshit Jain Also directs: Aalcot Biotech Private Limited | Director | 16 Mar 2021 | 5 Years 8 Months | Current |
Peer comparison
Cetrum Pharma-Consultant Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other support services to organizations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| New Age Markets in Electricity Private Limited | ₹97.41 Lakh (FY 2025) | 59.0% | New Delhi, Delhi, India | |||
| Nalanda Telecom System Private Limited | ₹97.37 Lakh (FY 2024) | -17.0% | Navi Mumbai, Maharashtra, India | |||
| Earthmars IT Solutions Private Limited | ₹97.35 Lakh (FY 2024) | 374.0% | Delhi, India | |||
| Ariadne Vivand International Private Limited | ₹97.27 Lakh (FY 2022) | 40.0% | Sibsagar, Assam, India | |||
| Premiere Gems Private Limited | ₹97.18 Lakh (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Cetrum Pharma-Consultant Private Limitedthis company | ₹97.17 Lakh (FY 2025) | ₹50.88 Lakh | 52.4% | 9.0% | Ludhiana, Punjab, India | |
| Questa Enneagram Private Limited | ₹97.15 Lakh (FY 2025) | 52.0% | Delhi, India | |||
| Paradise Visa Consulting Services Private Limited | ₹97.11 Lakh (FY 2024) | -6.0% | Delhi, India | |||
| Brainstem Pharmaceuticals (OPC) Private Limited | ₹97.06 Lakh (FY 2025) | 44.0% | Medchal, Telangana, India | |||
| Icegold Prints Private Limited | ₹97.05 Lakh (FY 2024) | Bangalore, Karnataka, India | ||||
| Rams Dental Lab Private Limited | ₹96.98 Lakh (FY 2025) | 8.0% | Chennai, Tamil Nadu, India |
To see the full peer comparison of Cetrum Pharma-Consultant Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cetrum Pharma-Consultant Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cetrum Pharma-Consultant Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cetrum Pharma-Consultant has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AAJCC3568M1ZD | Punjab | Active | 02 Nov 2021 |
To see the full GST registrations and return filing status of Cetrum Pharma-Consultant Private Limited, buy the company report.
Recent activity
Cetrum Pharma-Consultant Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Rakshit Jain was appointed as Director on 16 Mar 2021.
Frequently asked questions
Cetrum Pharma-Consultant is an active private limited company based in Ludhiana, Punjab, India. The company works in specialty, within the trading industry. It was incorporated on 16 March 2021 (5+ years old) and is registered under CIN U51909PB2021PTC052998.
Cetrum Pharma-Consultant has 2 current directors:
- Ruchika Jain - Director
- Rakshit Jain - Director
The latest financial statements of Cetrum Pharma-Consultant on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Cetrum Pharma-Consultant is 03AAJCC3568M1ZD, registered in Punjab.
The CIN (Corporate Identification Number) of Cetrum Pharma-Consultant is U51909PB2021PTC052998. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cetrum Pharma-Consultant was incorporated on 16 March 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Cetrum Pharma-Consultant by revenue are New Age Markets in Electricity Private Limited, Nalanda Telecom System Private Limited, Earthmars IT Solutions Private Limited, Ariadne Vivand International Private Limited, Premiere Gems Private Limited and 5 more, all in the same principal business activity (other support services to organizations).
Rakshit Jain was appointed as Director on 16 Mar 2021. Ruchika Jain was appointed as Director on 16 Mar 2021.
The registered office of Cetrum Pharma-Consultant is at Office II Iind Floor 3081 Dr Sham Singh Road Civil Lines, Ludhiana, Punjab, India – 141001.
Cetrum Pharma-Consultant operates in the trading industry, in the specialty segment.
Cetrum Pharma-Consultant can be reached at its registered office: Office II Iind Floor 3081 Dr Sham Singh Road Civil Lines, Ludhiana, Punjab, India – 141001.

